Lataa...
Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells
Acute myeloid leukemia (AML) is an aggressive malignancy lacking targeted therapy due to shared molecular and transcriptional circuits as well as phenotypic markers with normal hematopoietic stem cells (HSCs). Identifying leukemia specific markers expressed on AML or AML subtypes for therapeutic tar...
Tallennettuna:
| Julkaisussa: | J Cancer |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ivyspring International Publisher
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691696/ https://ncbi.nlm.nih.gov/pubmed/31413761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.28952 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|